BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 30839392)

  • 21. The overlap of upper functional gastrointestinal disorders with irritable bowel syndrome in Chinese outpatients: A multicenter study.
    Yao X; Yang YS; Cui LH; Sun G; Peng LH; Wang WF; Hyder Q; Zhang XL
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1584-93. PubMed ID: 26875585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea.
    Nam K; Kim N; Song HJ; Baik GH; Choi SC; Kim HJ; Lee JY; Park KS; Park SY; Park SJ
    J Gastroenterol; 2021 Jun; 56(6):537-546. PubMed ID: 33687537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study.
    Koloski NA; Jones M; Talley NJ
    Aliment Pharmacol Ther; 2016 Sep; 44(6):592-600. PubMed ID: 27444264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?
    Hughes PA; Zola H; Penttila IA; Blackshaw LA; Andrews JM; Krumbiegel D
    Am J Gastroenterol; 2013 Jul; 108(7):1066-74. PubMed ID: 23649183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled study of colonic immune activity and beta7+ blood T lymphocytes in patients with irritable bowel syndrome.
    Ohman L; Isaksson S; Lundgren A; Simrén M; Sjövall H
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10):980-6. PubMed ID: 16234043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target.
    Ford AC; Staudacher HM; Talley NJ
    Gut; 2024 Jun; 73(7):1199-1211. PubMed ID: 38697774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep disturbances in the irritable bowel syndrome and functional dyspepsia are independent of psychological distress: a population-based study of 1322 Australians.
    Koloski NA; Jones M; Walker MM; Keely S; Holtmann G; Talley NJ
    Aliment Pharmacol Ther; 2021 Sep; 54(5):627-636. PubMed ID: 34247414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune dysregulation in the functional gastrointestinal disorders.
    Keely S; Walker MM; Marks E; Talley NJ
    Eur J Clin Invest; 2015 Dec; 45(12):1350-9. PubMed ID: 26444549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome.
    Talley NJ; Holtmann G; Walker MM; Burns G; Potter M; Shah A; Jones M; Koloski NA; Keely S
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00064. PubMed ID: 31356481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia.
    Shah A; Gurusamy SR; Hansen T; Callaghan G; Talley NJ; Koloski N; Walker MM; Jones MP; Morrison M; Holtmann GJ
    Dig Dis Sci; 2022 Jun; 67(6):2299-2309. PubMed ID: 34392491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A correlation study between diarrhea-predominant irritable bowel syndrome complicated functional dyspepsia patients of Gan-stagnation Pi-deficiency syndrome and gastrointestinal hormones].
    Zhao L; Song W; Zhu P; Zhang Y; Bu P
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1168-72. PubMed ID: 25509256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT.
    Ivashkin VT; Poluektova EA; Glazunov AB; Putilovskiy MA; Epstein OI
    BMC Gastroenterol; 2019 Dec; 20(1):2. PubMed ID: 31892312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Jawarish Shahi: A special dosage form of herbal formulations for functional gastrointestinal disorders in Unani medicine- A comprehensive review.
    Mobeen A; Moazzam SW
    J Ethnopharmacol; 2022 Jul; 293():115319. PubMed ID: 35490900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptoms of mast cell activation syndrome in functional gastrointestinal disorders.
    Wilder-Smith CH; Drewes AM; Materna A; Olesen SS
    Scand J Gastroenterol; 2019 Nov; 54(11):1322-1325. PubMed ID: 31687861
    [No Abstract]   [Full Text] [Related]  

  • 35. Low Prevalence of Celiac Disease among Patients with Functional Gastrointestinal Disorders in Latvia.
    Dekante A; Daugule I; Pavlovics S; Kikuste I; Polaka I; Tzivian L; Kojalo I; Putnins V; Tolmanis I; Rumba-Rozenfelde I; Boka S; Vanags A; Leja M
    J Gastrointestin Liver Dis; 2020 Mar; 29(1):33-39. PubMed ID: 32176757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal immune activation in presumed post-infectious functional dyspepsia.
    Kindt S; Tertychnyy A; de Hertogh G; Geboes K; Tack J
    Neurogastroenterol Motil; 2009 Aug; 21(8):832-e56. PubMed ID: 19460107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndrome.
    Marasco G; Maida M; Cremon C; Barbaro MR; Stanghellini V; Barbara G
    Aliment Pharmacol Ther; 2023 Jul; 58(1):6-15. PubMed ID: 37038318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India.
    Goyal O; Nohria S; Dhaliwal AS; Goyal P; Soni RK; Chhina RS; Sood A
    Indian J Gastroenterol; 2021 Apr; 40(2):144-153. PubMed ID: 33226570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.
    Corsetti M; Caenepeel P; Fischler B; Janssens J; Tack J
    Am J Gastroenterol; 2004 Jun; 99(6):1152-9. PubMed ID: 15180740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-rated health and functional capacity in individuals reporting overlapping symptoms of gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome - a population based study.
    Jarbøl DE; Rasmussen S; Balasubramaniam K; Elnegaard S; Haastrup PF
    BMC Gastroenterol; 2017 May; 17(1):65. PubMed ID: 28521729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.